Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-19

FDA Approved: EXENATIDE — Original Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approves Amneal's original application for a generic version of exenatide for adults with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EXENATIDE (EXENATIDE)

Snippet

ORIG AP for EXENATIDE (EXENATIDE)